Targeted axillary dissection after neoadjuvant chemotherapy for highly selective patients with initial cN1 breast cancer: A single-center prospective trial
Chen, Xiuchun, Lu, Zhenduo, Wang, Chengzheng, Lyu, Minhao, Qiao, Jianghua, Sun, Xianfu, Li, Lianfang, Zhang, Chongjian, Liu, Zhenzhen
Published in Chinese medical journal (20.06.2024)
Published in Chinese medical journal (20.06.2024)
Get full text
Journal Article
Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trial
Yan, Min, Niu, Limin, Lv, Huimin, Zhang, Mengwei, Wang, Jing, Liu, Zhenzhen, Chen, Xiuchun, Lu, Zhenduo, Zhang, Chongjian, Zeng, Huiai, Zhao, Shengnan, Feng, Yajing, Sun, Huihui, Li, Huajun
Published in Nature communications (07.10.2023)
Published in Nature communications (07.10.2023)
Get full text
Journal Article
Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial
Wang, Chengzheng, Liu, Zhenzhen, Chen, Xiuchun, Qiao, Jianghua, Lu, Zhenduo, Li, Lianfang, Sun, Xianfu, Zhang, Chongjian, Yue, Xiayu, Xia, Qingxin, Zhang, He, Yan, Min
Published in Nature communications (20.10.2023)
Published in Nature communications (20.10.2023)
Get full text
Journal Article
Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer
Zhu, Jiujun, Jiao, Dechuang, Yan, Min, Chen, Xiuchun, Wang, Chengzheng, Lu, Zhenduo, Li, Lianfang, Sun, Xianfu, Qin, Li, Guo, Xuhui, Zhang, Chongjian, Qiao, Jianghua, Li, Jianbin, Fan, Zhimin, Wang, Haibo, Zhang, Jianguo, Yin, Yongmei, Fu, Peifen, Geng, Cuizhi, Jin, Feng, Jiang, Zefei, Cui, Shude, Liu, Zhenzhen
Published in Frontiers in oncology (29.04.2021)
Published in Frontiers in oncology (29.04.2021)
Get full text
Journal Article
ATF2 inhibits ani-tumor effects of BET inhibitor in a negative feedback manner by attenuating ferroptosis
Wang, Lina, Chen, Yibing, Mi, Yanjun, Qiao, Jianghua, Jin, Huan, Li, Juntao, Lu, Zhenduo, Wang, Qiming, Zou, Zhengzhi
Published in Biochemical and biophysical research communications (18.06.2021)
Published in Biochemical and biophysical research communications (18.06.2021)
Get full text
Journal Article
Optimal neoadjuvant treatment and prognostic factors in patients with HR-positive/HER2-positive early or locally advanced breast cancer: A national real-world study in China
Liu, Zhenzhen, Zhu, Jiujun, Wang, Chengzheng, Lu, Zhenduo, Chen, Xiuchun, Li, Lianfang, Sun, Xianfu, Zhang, Chongjian, Qiao, Jianghua, Yan, Min
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Pathological response and predictive role of tumour-infiltrating lymphocytes in HER2-positive early breast cancer treated with neoadjuvant pyrotinib plus trastuzumab and chemotherapy (Panphila): a multicentre phase 2 trial
Liu, Zhenzhen, Wang, Chengzheng, Chen, Xiuchun, Zhu, Jiujun, Sun, Xianfu, Xia, Qingxin, Lu, Zhenduo, Qiao, Jianghua, Zhou, Yong, Wang, Haixue, Wang, Yi, Yan, Min
Published in European journal of cancer (1990) (01.04.2022)
Published in European journal of cancer (1990) (01.04.2022)
Get full text
Journal Article
HN1L promotes migration and invasion of breast cancer by up‐regulating the expression of HMGB1
Jiao, Dechuang, Zhang, Jingyang, Chen, Ping, Guo, Xuhui, Qiao, Jianghua, Zhu, Jiujun, Wang, Lina, Lu, Zhenduo, Liu, Zhenzhen
Published in Journal of cellular and molecular medicine (01.01.2021)
Published in Journal of cellular and molecular medicine (01.01.2021)
Get full text
Journal Article
Updated results from a phase 2 study on dalpiciclib and pyrotinib, a dual-oral chemotherapy-free regimen in HER2-positive advanced breast cancer (DAP-HER-01)
Yan, Min, Niu, Limin, Lv, Huimin, Zhang, Mengwei, Liu, Zhenzhen, Chen, Xiuchun, Lu, Zhenduo, Zhang, Chongjian, Zeng, Huiai, Zhao, Shengnan, Feng, Yajing, Wang, Jing, Sun, Huihui, Li, Huajun
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy
Yang, Hanzhao, Sun, Yadong, Wang, Peili, Qiao, Jianghua, Li, Lianfang, Lu, Zhenduo, Sun, Xianfu, Zhang, Chongjian, Chen, Xiuchun, Yan, Min, Cui, Shude, Wang, Chengzheng, Liu, Zhenzhen
Published in Medical science monitor (16.07.2023)
Published in Medical science monitor (16.07.2023)
Get full text
Journal Article
Abstract PO2-16-06: Treatment Patterns of Neoadjuvant Therapy in Chinese Patients with HR-Positive/HER2-Positive Early or Locally Advanced Breast Cancer: A Real-World Study Using NCID Data in 2019-2022
Liu, Zhenzhen, Zhu, Jiujun, Wang, Chengzheng, Lu, Zhenduo, Chen, Xiuchun, Li, Lianfang, Sun, Xianfu, Zhang, Chongjian, Qiao, Jianghua, Yan, Min
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract 6439: Next-generation sequencing based detection of HER2 copy number predicts pathological response to neoadjuvant therapy in HER2 positive breast cancer
Dai, Hao, Jiao, Dechuang, Guo, Xuhui, Qiao, Jianghua, Li, anfang, Lu, Zhenduo, Chen, Xiuchun, Wang, Chengzheng, Yan, Min, Liu, Zhenzhen
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73
Lu, Zhenduo, Jiao, Dechuang, Qiao, Jianghua, Yang, Sen, Yan, Min, Cui, Shude, Liu, Zhenzhen
Published in Molecular cancer (14.05.2015)
Published in Molecular cancer (14.05.2015)
Get full text
Journal Article
Establishment of a model for predicting sentinel lymph node metastasis in early breast cancer based on contrast-enhanced ultrasound and clinicopathological features
Wang, Lina, Li, Juntao, Qiao, Jianghua, Guo, Xiaoxia, Bian, Xiaolin, Guo, Lanwei, Liu, Zhenzhen, Lu, Zhenduo
Published in Gland surgery (01.05.2021)
Published in Gland surgery (01.05.2021)
Get full text
Journal Article
Abstract PO3-27-12: Dexamethasone is necessary for preventing acute emesis induced by anthracycline/cyclophosphamide chemotherapy (HELEN-009) : a multicenter, randomized, open-labeled phase 3 trial
Chen, Xiuchun, Dechuang, Jiao, Zhang, Chongjian, Sun, Xianfu, Lu, Zhenduo, Li, Lianfang, Qiao, Jianghua, Wang, Chengzheng, Yan, Min, Feng, Yueqing, Wei, Ya, Liu, Zhenzhen
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract PO3-28-04: Ganglioside-Monosialic Acid for Prevention of Peripheral Neuropathy Induced by nab-Paclitaxel in Breast Cancer Patients (HELEN-004): A Randomized, Double-Blind, Phase II Trial
Lu, Zhenduo, Jiao, Dechuang, Qiao, Jianghua, Zhang, Hao, Dai, Hao, Sun, Xianfu, Yan, Min, Zhou, Yong, Li, Lianfang, Wang, Chengzheng, Chen, Xiuchun, Liu, Zhenzhen
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy Regimen
Zhu, Jiujun, Jiao, Dechuang, Wang, Chengzheng, Lu, Zhenduo, Chen, Xiuchun, Li, Lianfang, Sun, Xianfu, Qin, Li, Guo, Xuhui, Zhang, Chongjian, Qiao, Jianghua, Yan, Min, Cui, Shude, Liu, Zhenzhen
Published in Cancers (17.09.2022)
Published in Cancers (17.09.2022)
Get full text
Journal Article
Abstract PO1-27-05: De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab in HER2-positive early breast cancer (HELEN-006):a randomized,phase 3 trial
Liu, Zhenzhen, Chen, Xiuchun, Qiao, Jianghua, Dechuang, Jiao, Wang, Chengzheng, Sun, Xianfu, Lu, Zhenduo, Li, Lianfang, Zhang, Chongjian, Yan, Min, Wei, Ya, Bo, Chen, Feng, Yueqing, Deng, Miao, Ma, Mingde
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract PO1-28-07: Neoadjuvant docetaxel plus cisplatin versus docetaxel plus doxorubicin and cyclophosphamide in early-stage triple-negative breast cancer (HNBC-001): results from a multicenter, randomized controlled, open-label phase II trial
Jiao, Dechuang, Qiao, Jianghua, Wang, Chengzheng, Li, Juntao, Sun, Xianfu, Lu, Zhenduo, Zhang, Chongjian, Li, Lianfang, Yan, Min, Feng, Yueqing, Zhou, Yong, Deng, Miao, Liu, Xinlan, Ma, Mingde, Jia, Haiquan, Xia, Qingxin, Chen, Xiuchun, Liu, Zhenzhen
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article